Team: Clinical Operations

Home » Our Mission » Who We Are » Staff »
Yasmeen Alshabasy
Yasmeen Alshabasy

Yasmeen Alshabasy

Senior Clinical Research Associate

Yasmeen Alshabasy earned a bachelor’s degree in science in society with a concentration in sociology in 2020 from Wesleyan University. Prior to joining MAPS Public Benefit Corporation (MAPS PBC), Yasmeen served as a writing educator at an all-girls middle school in Brooklyn, NY. Previously, Yasmeen researched at the Johns Hopkins Cochlear Center for Hearing and Public Health where she investigated the impact of dualsensory impairment on health care interactions. At Harvard T.H Chan School of Public Health, Yasmeen studied the impact of personal and work-related burnout on suicidal ideation and behavior, which generated her personal interest into the impacts of systemic and generational trauma.

At MAPS PBC, Yasmeen is currently serving as a senior clinical research associate on the pivotal program team, working on Phase 3 MDMA-assisted therapy studies for PTSD treatment.

She is passionate about the potential of psychedelic healing modalities to restore mind-body-spirit wellbeing and is thrilled to be joining a team devoted to collective healing, community care, and harm reduction. Yasmeen believes that all humans organically have the capacity to heal, and psychedelics offer a powerful tool to actualize transformation. She is humbled to continue learning how plant medicine may alter our neurochemistry, transform our consciousness, and promote collective healing. In Yasmeen’s free time, she enjoys biking, cooking, painting, breathwork, and being in nature.

MAPS Public Benefit Corporation

Our Mission
Who We Are
Contact Us
Privacy Policy

Cookie Policy

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

Therapy Education for Healthcare Providers

Our Commitment to Therapy Education


MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.

Stay Up-to-Date about the MDMA-AT Education Program

You have Successfully Subscribed!